Rice Hall James & Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.06M | Sell |
|
|||||
|
2024
Q3 | $3.79M | Buy |
|
|||||
|
2024
Q2 | $1.83M | Sell |
|
|||||
|
2024
Q1 | $3.67M | Sell |
|
|||||
|
2023
Q4 | $6.66M | Buy |
|
|||||
|
2023
Q3 | $7.84M | Buy |
|
|||||
|
2023
Q2 | $14M | Sell |
|
|||||
|
2023
Q1 | $26.1M | Sell |
|
|||||
|
2022
Q4 | $16.2M | Sell |
|
|||||
|
2022
Q3 | $24.2M | Sell |
|
|||||
|
2022
Q2 | $15M | Sell |
|
|||||
|
2022
Q1 | $21.7M | Sell |
|
|||||
|
2021
Q4 | $18.2M | Buy |
|
|||||
|
2021
Q3 | $25.6M | Sell |
|
|||||
|
2021
Q2 | $27.4M | Sell |
|
|||||
|
2021
Q1 | $30.9M | Sell |
|
|||||
|
2020
Q4 | $31.8M | Sell |
|
|||||
|
2020
Q3 | $28.4M | Buy |
|
|||||
|
2020
Q2 | $25.2M | Buy |
|
|||||
|
2020
Q1 | $15.2M | Sell |
|
|||||
|
2019
Q4 | $17.3M | Sell |
|
|||||
|
2019
Q3 | $14M | Buy |
|
|||||
|
2019
Q2 | $11.4M | Buy |
|
|||||
|
2019
Q1 | $1.84M | Buy |
|
|||||
|
2018
Q4 | $668K | Buy |
|
|||||
|
2018
Q3 | $606K | Buy |
|